Vericel Corporation (VCEL) Financials

VCEL Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 502.9 million 132.8 million
March 31, 2026 485.6 million 129.4 million
Dec. 31, 2025 488.0 million 133.3 million
Sept. 30, 2025 453.3 million 131.4 million

VCEL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 14.3 million -11.3 million
March 31, 2026 15.1 million 11.3 million
Dec. 31, 2025 802000 8.4 million
Sept. 30, 2025 19.5 million 8.7 million

VCEL Net Income

No data available :(

VCEL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 162.5 million 78.4 million 92.7 million
March 31, 2026 145.3 million 80.4 million 14.2 million
Dec. 31, 2025 137.5 million - 84.2 million
Sept. 30, 2025 135.4 million - 98.0 million

VCEL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 50.9 million
March 31, 2026 50.8 million
Dec. 31, 2025 52.1 million
Sept. 30, 2025 51.9 million

VCEL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.9 million 7.5 million 48.5 million -
March 31, 2026 1.3 million 8.1 million 49.2 million -
Dec. 31, 2025 14.2 million 7.3 million 43.5 million -
Sept. 30, 2025 2.6 million 6.3 million 39.8 million -

VCEL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 77.5 million 21.1 million
March 31, 2026 68.4 million 19.2 million
Dec. 31, 2025 92.9 million 19.8 million
Sept. 30, 2025 67.5 million 17.9 million

VCEL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VCEL

Price: $44.20

52 week price:
28.95
49.32

Earnings Per Share: 0.48 USD

P/E Ratio: 96.54

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 122353

Ebitda: -4.7 million

Market Capitalization: 2.4 billion

Links: